5-[(2,4-Difluorophenyl)methyl]-4-methyl-1,3-thiazol-2-amine hydrobromide

Catalog No. :
ACXJUJ554
CAS No. :
1795493-24-1
Molecular Formula :
C11H11BrF2N2S
Molecular Weight :
321.19

IUPAC Name:5-(2,4-difluorobenzyl)-4-methylthiazol-2-amine hydrobromide

5-[(2,4-Difluorophenyl)methyl]-4-methyl-1,3-thiazol-2-amine hydrobromide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$135.00Login to see priceInquiryInquiry
100mg95%$192.00Login to see priceInquiryInquiry
250mg95%$267.00Login to see priceInquiryInquiry
1g95%$641.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-[(2,4-Difluorophenyl)methyl]-4-methyl-1,3-thiazol-2-amine hydrobromide
IUPAC Name5-(2,4-difluorobenzyl)-4-methylthiazol-2-amine hydrobromide
MDL No.MFCD28118512
Molecular FormulaC11H11BrF2N2S
Molecular Weight321.19
SMILESNC1=NC(C)=C(CC2=CC=C(F)C=C2F)S1.[H]Br
InChI KeyRDXQHPNMCACBPX-UHFFFAOYSA-N
Synonym2-Thiazolamine, 5-[(2,4-difluorophenyl)methyl]-4-methyl-, hydrobromide (1:1);5-[(2,4-Difluorophenyl)methyl]-4-methyl-1,3-thiazol-2-amine hydrobromide
CAS No.1795493-24-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACXJUJ554 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXJUJ554 route product structure diagram
    ACXJUJ5541795493-24-1
Inquiry

2. ACXJUJ554 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXJUJ554 route product structure diagram
    ACXJUJ5541795493-24-1
Inquiry

Comments (0)